Revenue, 2025

USD 4.92 Billion

Forecast, 2035

USD 12.59 Billion

CAGR, 2026-2035

9.85%

Report Coverage

Global

Companion Animal Genetics Market Trends for 2026

The global companion animal genetics market size was estimated at USD 4.92 billion in 2025 and is predicted to increase from USD 5.4 billion in 2026 to approximately USD 12.59 billion by 2035, expanding at a CAGR of 9.85% from 2026 to 2035. The growing pet ownership globally is increasing the demand for companion animal genetics, for their early disease diagnosis and behaviour prediction. The growing genetic disorders, personalized veterinary care, technological advancement, and launch of new genetic testing solutions are also enhancing the market growth.

Quik Facts

• Companion animal genetics sector pushed the market to USD 5.4 billion by 2026.
• Long-term projections show USD 12.59 billion valuation by 2035.
• Growth is expected at a steady CAGR of 9.85% in between 2026 to 2035.
• North America held the major revenue share of 42% in the global companion animal genetics market in 2025.
• Asia Pacific held 20% share of the market in 2025 and is expected to grow at the fastest CAGR of 11.8% during the forecast period.
• By animal type, the dogs segment held a dominant revenue share of 58% of the market in 2025.
• By animal type, the cats segment held 24% of market share in 2025 and is expected to grow at the fastest CAGR of 10.8% during the forecast period.
• By product type, the genetic testing kits segment held a dominant revenue share of 62% of the market in 2025 and is expected to grow at the fastest CAGR of 10.4% during the forecast period.
• By technology type, the PCR segment held a dominant revenue share of 34% of the market in 2025.
• By technology type, the next-generation sequencing (NGS) segment held 29% of market share in 2025 and is expected to grow at the fastest CAGR of 12.7% during the forecast period.
• By application type, the disease diagnosis segment held a dominant position in the market with a share of 30% in 2025.
• By application type, the genetic disease prevention segment held 22% of the market share in 2025 and is expected to grow at the fastest CAGR of 11.3% during the forecast period.

What are the Companion Animal Genetics?

The companion animal genetics market is driven by a rise in pet humanization and a shift towards preventive healthcare. Companion animal genetics refers to the branch of genetics focused on the study of genes, genetic variation, and heredity in pet animals. They are used for early disease diagnosis, breed identification, improved breeding, behavioral understanding, disease prevention, nutritional planning, and personalized treatment development.

What are the Applications of AI in the Companion Animal Genetics Market?

AI offers a wide range of applications for companion animal genetics, such as analysis of large genomic datasets, as well as predicting the risk of inherited diseases. It also assists in breeding optimization, behavior prediction, and detection of genetic patterns leading to diseases. AI also helps in the veterinary drug discovery, development, and testing, as well as supporting the precision medicine and personalized treatment plans.

What are the Trends & Future Outlook of the Companion Animal Genetics Market?

Expanding Pet Humanization

A rise in pet humanization is increasing the willingness of the pet owner to invest in the health and well-being of their pet. This, in turn, is increasing the use of companion animal genetics for early disease detection.

Shift Towards Preventive Care

Growing pet health awareness is increasing the demand for preventive veterinary care options in order to enhance pet lifespan and reduce long-term treatment. This is increasing the use of companion animal genetics for the identification of diseases before the occurrence of symptoms.

Blooming Technological Innovations

Growing technological advancements are driving the development of new DNA testing kits, next-generation sequencing, bioinformatics tools, and whole-genome analysis. These innovations focus on enhancing the speed, accuracy, and affordability of companion animal genetics.

Key Indicators and Highlights

Segmental Insights

By Animal Type Insights

The Dogs Segment Dominated the Market With 58% in 2025

The dogs segment led the companion animal genetics market with 58% share in 2025, due to high dog ownership globally, which increased demand for genetic screening. Growth in awareness of breed-specific diseases also supported the testing adoption. Moreover, premium pet care spending also increased its diagnostic usage.

The cats segment held the second-largest share of 24% of the market in 2025 and is expected to witness the fastest growth with a CAGR of 10.8% during the forecast period, due to increasing cat adoption in urban areas, which drives companion animal genetic testing demand. Expanding genetic disease awareness in felines is also increasing their use. The presence of affordable testing kits and veterinary care services is promoting their penetration among cat owners.

The horses segment held 10% of the companion animal genetics market share in 2025, due to growing demand for performance and breeding optimization, driving their genetic testing. Equine disease screening adoption is rising in the sports industry, which fuels the demand for companion animal genetics. Veterinary advancements and selective breeding programs are also utilizing them to support precision breeding.

By Product Type Insights

The Genetic Testing Kits Segment Dominated the Market With 62% in 2025

The genetic testing kits segment accounted for the highest revenue share of 62% of the companion animal genetics market in 2025 and is expected to show the highest growth with a CAGR of 10.4% during the forecast period, driven by their easy-to-use home kits, which increased consumer adoption rapidly. E-commerce expansion also enhanced their accessibility. Cost-effective solutions also contributed to their mass-market penetration.

The genetic services segment held the second-largest share of 38% of the market in 2025, driven by advanced diagnostic services, which support complex testing needs. Their high accuracy and customization are also attracting professional users. Moreover, growing veterinary partnerships and personalized veterinary care also boost service utilization.

By Technology Insights

The PCR Segment Dominated the Market With 34% in 2025

The PCR segment held a major revenue share of 34% of the companion animal genetics market in 2025, as they are cost-effective and widely available technology, which supported the routine testing. High accuracy, sensitivity, and reliability ensured their continued usage. Established infrastructure and its multiple applications also promoted their adoption.

The next-generation sequencing (NGS) segment held the second-largest share of 29% of the market in 2025 and is expected to expand rapidly with a CAGR of 12.7% during the forecast period, as it provides high-resolution genomic insights for precision diagnostics. Declining sequencing costs and expanding research applications are also increasing their adoption rates. Their better disease detection and expanding personalized medicine trends are also increasing their demand.

The microarray segment held 21% of the companion animal genetics market share in 2025, as it enables simultaneous analysis of multiple genetic markers. Growing demand for comprehensive screening is also increasing its usage. Improved efficiency, accuracy, and affordability enhance laboratory adoption for various veterinary diagnostics.

By Application Insights

The Disease Diagnosis Segment Dominated the Market With 30% in 2025

The disease diagnosis segment contributed the biggest revenue share of 30% of the companion animal genetics market in 2025, due to the growth in prevalence of genetic disorders, which increased companion animal genetic testing demand. Early diagnosis and shift to preventive healthcare also increased their use. Additionally, growth in veterinary recommendations also enhanced their adoption.

The genetic disease prevention segment held the second-largest share of 22% of the market in 2025 and is expected to gain the highest share with a CAGR of 11.3% during the forecast period, due to preventive healthcare trends, which boost proactive testing. Rising awareness of hereditary conditions is also increasing their use. Insurance integration, accessibility of direct-to-consumer kits, and affordability also support their use.

The breed identification segment held 18% of the companion animal genetics market share in 2025, driven by growing pet owners seeking breed verification for better care decisions. Adoption from shelters and increased awareness also support testing growth. Additionally, non-invasive approaches and accuracy are also increasing their use for better pet care and early disease detection.

The trait testing segment held 15% of the market share in 2025, due to behavioral and physical trait insights of companion animal genetics, which attracts pet owners. Breeders utilize testing for selective breeding, where enhanced consumer curiosity drives demand. High emotional appeal, advancements in genomics research, and breed customization are also increasing their adoption rates.

The research & development segment held 15% of the market share in 2025, due to growing investments in veterinary genomics, which drives R&D. Academic collaborations expand genetic databases, which propel the use of companion animal genetics. Growing innovations with the use of AI and bioinformatics integration are also supporting new product development.

Regional Insights

High Pet Ownership Drives North America

North America dominated the companion animal genetics market with 42% in 2025, due to high pet ownership and spending. Advanced veterinary infrastructure also supported its adoption, where the presence of strong key players also contributed to their increased innovations. Growth in animal health awareness and R&D activities also increased their adoption and advancements, which enhanced the market growth.

U.S. Market Trends

The U.S. consists of a high pet population, which increases the demand for companion animal genetics. The growing pet health awareness is also increasing their adoption rates. Additionally, growing technological advancements and high pet healthcare spending are also increasing their innovations and adoption rates.

Rapid Urbanization Boosts the Asia Pacific

Asia Pacific held 20% share of the companion animal genetics market in 2025 and is expected to grow at the fastest CAGR of 11.8% during the forecast period, due to rapid urbanization and growing pet ownership. Rising disposable income and expanding veterinary infrastructure are also increasing their use. Increasing awareness, adoption of new technologies, and expanding online services are also promoting the market growth.

China Market Trends

Growing pet ownership in China is increasing the demand for companion animal genetics, where the growing awareness of genetic testing is also increasing their use. E-commerce expansion, increasing disposable income, and growing pet humanization trends are also increasing their use and accessibility. Additionally, expanding veterinary infrastructure and biotech industries are also enhancing their use.

Companion Animal Genetics Market Value Chain Analysis

R&D

• The R&D of companion animal genetics focuses on utilizing next-generation sequencing and AI-powered biobanks for breed identification and predictive precision medicine.
• Key players: Embark Veterinary, Inc., Zoetis Inc., Mars Petcare.

Clinical Trials and Regulatory Approvals

• The clinical performance, analytical validity, and identification of disease-linked genetic markers are evaluated in the clinical trials and regulatory approvals of companion animal genetics.
• Key players: Zoetis Inc., Mars Petcare.

Formulation and Final Dosage Preparation

• The formulation and final dosage preparation of the companion animal genetics involves the development of next-generation sequencing or PCR platforms with the use of stabilizing buffers, reagents, and primers.
• Key players: Embark Veterinary, Inc., Zoetis Inc., Mars Petcare.

Packaging and Serialization

• The packaging and serialization of companion animal genetics involves the use of tamper-evident, barcoded medical-grade packaging and GS1-compliant tracking systems.
• Key players: Embark Veterinary, Inc., Zoetis Inc., Mars Petcare.

Distribution to Hospitals, Pharmacies

• The specialized veterinary wholesalers and national medical distributors are responsible for the distribution of companion animal genetics products to the hospitals and pharmacies.
• Key players: Zoetis Inc., IDEXX Laboratories.

Patient Support and Services

• Breeder tools, expert veterinary genetic counseling, and personalized wellness and nutrition strategies are provided in the patient support and services of the companion animal genetics.
• Key players: Embark Veterinary, Orivet, Mars Petcare.

Who are the Companion Animal Genetics Market Top Vendors and What are Their Offerings?

SWOT Analysis

Strengths

• Companion animal genetics offers accurate disease diagnosis with identification of causative agents, which increases their demand.
• It enables selective breeding and early disease detection, reducing incidences of genetic disorders.
• It is also used for behavioral insights by understanding inherited traits.
• It is also used in the development of personalized treatment options and in maintaining the genetic diversity of the breeds.

Weaknesses

• The high cost associated with advanced DNA tests acts as the major weakness in the companion animal genetics market, limiting their adoption rates.
• Limited genetic data and awareness also reduce their use.

Opportunities

• The expanding pet genomics industry is increasing the adoption of companion animal genetics solutions.
• Growing focus on precision medicine for veterinary care is also increasing its use.
• Advancements in gene therapies are also increasing their use.
• Expanding behavioral genetics applications are also increasing their adoption rates.

Threats

• Ethical concerns leading to the misuse of genetic information limit the adoption of companion animal genetics.
• Limited skilled professionals, stringent regulations, and rapid technological changes also reduce their use and innovations.

Recent Developments in the Companion Animal Genetics Market

• In March 2026, a definitive acquisition agreement with a $160 million deal was announced between Zoetis and Neogen Corporation. With the agreement, Zoetis will acquire Neogen’s beef, dairy genomics, and its cutting-edge technologies, offering accurate, deeper insights, and scalable genetic testing for the companion and livestock industries.
• In August 2025, a collaboration between POP, Embark Veterinary, and Innovative Pet Lab announced the launch of a 90-day canine health study to offer personalized nutrition, behavior tracking, and biological data to support long-term vitality and immune health. This study will offer over $600 in free health tools, like Embark's DNA test, POP's science-backed supplement POP-Topper, and Innovative Pet Lab's gut biomarker test kits to the participants.

Segments Covered in the Report

By Animal Type

• Dogs
  • Purebred Dogs
  • Mixed Breed Dogs
• Cats
  • Purebred Cats
  • Mixed Breed Cats
• Horses
• Others (Birds, Rabbits, Small Mammals)

By Product Type

• Genetic Testing Kits
  • DNA Testing Kits
  • Health Screening Kits
  • Breed Identification Kits
• Genetic Services
  • Disease Screening Services
  • Trait Testing Services
  • Ancestry & Lineage Services

By Technology

• PCR (Polymerase Chain Reaction)
• Microarray
• Next-Generation Sequencing (NGS)
• Others (SNP Genotyping, CRISPR-based tools)

By Application

• Disease Diagnosis
• Breed Identification
• Trait Testing
• Genetic Disease Prevention
• Research & Development

By End User

• Veterinary Clinics
• Animal Hospitals
• Research Institutes
• Pet Owners/Breeders

By Distribution Channel

• Direct Sales
• Online Platforms
• Veterinary Channels
• Retail Stores

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA